Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
34.55
+0.60 (1.77%)
At close: Feb 21, 2025, 4:00 PM
34.40
-0.15 (-0.43%)
After-hours: Feb 21, 2025, 6:57 PM EST
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $1.97 billion as of February 21, 2025. Its market cap has increased by 13.92% in one year.
Market Cap
1.97B
Enterprise Value
1.22B
1-Year Change
13.92%
Ranking
Category
Stock Price
$34.55
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $1.97B, an increase of 143.05%. That is a compound annual growth rate of 73.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 1.97B | -23.73% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |